Brain metastases are the most common central nervous system tumors in adults, and incidence of brain metastases is increasing due to both improved diagnostic techniques (e.g. magnetic resonance imaging) and increased cancer patient survival through advanced systemic treatments. Outcomes of patients remain disappointing and treatment options are limited, usually involving multimodality approaches. Brain metastases represent an unmet medical need in solid tumor care, especially in breast cancer, where brain metastases are frequent and result in impaired quality of life and death. Challenges in the management of brain metastases have been highlighted in this review. Innovative research and treatment strategies, including prevention approaches ...
Brain metastases (BM) occur in 20–40% of patients with cancer and 60–75% of patients with BM become ...
Brain metastasis is an end stage in breast cancer progression. Traditional treatment options have mi...
An estimated 20% of all patients with cancer will develop brain metastases, with the majority of bra...
Brain metastases are the most common central nervous system tumors in adults, and incidence of brain...
Breast cancer is the leading cause of brain metastases in women. Large randomized clinical trials th...
Brain metastases are a common, and frequently challenging, clinical problem in the contemporary mana...
Metastases from cells outside of the central nervous system are the most common cancer found in the ...
Brain metastases are a significant cause of morbidity and mortality in patients with breast cancer. ...
Development of brain metastases can occur in up to 30–50% of patients with breast cancer, representi...
The treatment of brain metastases has progressed during these last years; new techniques have emerge...
Brain metastases are frequent and dreadful complications of cancer especially lung, breast, colorect...
Brain metastasis are the most common intracranial malignancy in the adult population. Their incidenc...
Abstract Breast cancer is the most common cancer in women and the second leading cause of cancer‐rel...
The discovery of various driver pathways and targeted small molecule agents/antibodies have revoluti...
Brain metastases (BMs) are an important source of morbidity and mortality in patients with metastati...
Brain metastases (BM) occur in 20–40% of patients with cancer and 60–75% of patients with BM become ...
Brain metastasis is an end stage in breast cancer progression. Traditional treatment options have mi...
An estimated 20% of all patients with cancer will develop brain metastases, with the majority of bra...
Brain metastases are the most common central nervous system tumors in adults, and incidence of brain...
Breast cancer is the leading cause of brain metastases in women. Large randomized clinical trials th...
Brain metastases are a common, and frequently challenging, clinical problem in the contemporary mana...
Metastases from cells outside of the central nervous system are the most common cancer found in the ...
Brain metastases are a significant cause of morbidity and mortality in patients with breast cancer. ...
Development of brain metastases can occur in up to 30–50% of patients with breast cancer, representi...
The treatment of brain metastases has progressed during these last years; new techniques have emerge...
Brain metastases are frequent and dreadful complications of cancer especially lung, breast, colorect...
Brain metastasis are the most common intracranial malignancy in the adult population. Their incidenc...
Abstract Breast cancer is the most common cancer in women and the second leading cause of cancer‐rel...
The discovery of various driver pathways and targeted small molecule agents/antibodies have revoluti...
Brain metastases (BMs) are an important source of morbidity and mortality in patients with metastati...
Brain metastases (BM) occur in 20–40% of patients with cancer and 60–75% of patients with BM become ...
Brain metastasis is an end stage in breast cancer progression. Traditional treatment options have mi...
An estimated 20% of all patients with cancer will develop brain metastases, with the majority of bra...